Burek Vitomir
Klinika za infektivne bolesti "Dr. Fran Mihaljević", Zagreb, Hrvatska.
Acta Med Croatica. 2005;59(5):405-12.
Accurate diagnosis of viral hepatitis is based on determination of specific viral markers. In HBV infection they include HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HBc, IgM anti-HBc, and HBV DNA. There are patients with HBV marker constellation indicating serologic recovery, but with HBV DNA in the liver indicating continuous viral replication. Mutations have been described in all four HBV genes. It is important to take into account the main precore mutation which leads to a decrease or complete inhibition of HBeAg production (HBeAg negative HBV infection). Diagnostically most important are surface gene mutations because they can result in the false diagnosis or delay in diagnosis in important groups of patients. Anti-HCV and HCV RNA are found in sera of patients with HCV infection. A false positive result is possible with ELISA, especially in patients with low c/o ratio and in all individuals with a low risk of HCV infection. It is necessary to confirm ELISA positivity with confirmation techniques (western blot, immunoblot). There are qualitative and quantitative assays for HCV RNA determination. HCV genotyping should be done, since different viral genotypes respond differently to therapy and therapeutic protocols are different. It is possible to determine HCVAg free or complexed with the antibody. Determination of free HCVAg could enable the diagnosis of acute HCV infection. There are some clinical situations where the interpretation of HBV and HCV markers is difficult because of ambiguous interpretation and "unusual" constellation. Attention should be focused on simultaneous infection within other hepatitis viruses or other viruses like HIV. Replication of one virus could have a direct influence on the replication and expression of another virus.
病毒性肝炎的准确诊断基于特定病毒标志物的测定。在乙肝病毒(HBV)感染中,这些标志物包括乙肝表面抗原(HBsAg)、乙肝表面抗体(抗-HBs)、乙肝e抗原(HBeAg)、乙肝e抗体(抗-HBe)、乙肝核心抗体(抗-HBc)、IgM型乙肝核心抗体(IgM抗-HBc)以及乙肝病毒脱氧核糖核酸(HBV DNA)。有些患者的HBV标志物组合提示血清学恢复,但肝脏中存在HBV DNA,表明病毒在持续复制。已在HBV的所有四个基因中发现了突变。考虑主要的前核心区突变很重要,该突变会导致HBeAg产生减少或完全抑制(HBeAg阴性HBV感染)。在诊断方面,表面基因突变最为重要,因为它们可能导致重要患者群体的误诊或诊断延迟。丙肝病毒(HCV)感染患者的血清中可检测到抗-HCV和HCV RNA。酶联免疫吸附测定(ELISA)可能出现假阳性结果,尤其是在临界值/比值较低的患者以及所有HCV感染风险较低的个体中。必须用确证技术(免疫印迹法、免疫转印法)来确证ELISA阳性结果。有用于测定HCV RNA的定性和定量检测方法。应该进行HCV基因分型,因为不同的病毒基因型对治疗的反应不同,治疗方案也有所不同。可以测定游离的或与抗体结合的HCV抗原(HCVAg)。游离HCVAg的测定有助于急性HCV感染的诊断。在某些临床情况下,由于解释不明确和“异常”的标志物组合,对HBV和HCV标志物的解读会很困难。应关注同时感染其他肝炎病毒或其他病毒(如人类免疫缺陷病毒(HIV))的情况。一种病毒的复制可能会对另一种病毒的复制和表达产生直接影响。